Repurposing of the antimalarial agent tafenoquine to combat MRSA

Pengfei She, Yifan Yang, Linhui Li, Yimin Li, Shasha Liu, Zehao Li, Linying Zhou, Yong Wu · 2023

Read Repurposing of the antimalarial agent tafenoquine to combat MRSA by Pengfei She, Yifan Yang, Linhui Li, Yimin Li, Shasha Liu, Zehao Li, Linying Zhou, Yong Wu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10734505.txt.

Description

Pengfei She and co-authors repurpose a malaria drug against staph in a 2023 study. Tafenoquine fights malaria; nobody had tested it on bacteria. The team checked it against drug resistant Staphylococcus aureus, the MRSA menace, in free cells, in biofilms, and in hardy persister cells. The drug hit all three forms.

Its weapon is the bacterial membrane, the studies show. Mouse tests added safety and effect evidence in living animals. Old drugs with new targets are precious, since fresh antibiotics are rare and resistance grows. A known safety record shortens the road to clinic. The work makes the malaria pill a candidate for resistant skin and wound infections.

Catalog record

CREATORPengfei She, Yifan Yang, Linhui Li, Yimin Li, Shasha Liu, Zehao Li, Linying Zhou, Yong Wu
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10734505

Browse the full library · About the Tower of Babel